Clinical relevance of fungal susceptibility testing and antifungal resistance

Clinical Microbiology Newsletter

Volumn 22, Issue 18, 2000, Pages 137-140

  Espinel Ingroff, Ana ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; DISEASE SEVERITY; HOST; HUMAN; IMMUNE RESPONSE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; REVIEW; TREATMENT FAILURE; VIRULENCE;

EID: 0034666106     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(01)80005-2     Document Type: Article

References (18)

1. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections
2. Antifungal agents and susceptibility tests
3. Clinical relevance of antifungal resistance
4. Incidence of polyene-resistant yeasts recovered from clinical specimens
5. Resistance of Candida albicans to azole antifungal agents
6. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
7. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata
8. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
9. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance
10. Molecular mechanisms of drug resistance in fungi
11. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: The role of antifungal susceptibility testing
12. Correlation of in vitro susceptibility test results with in vivo response: Flucytosine therapy in a systemic candidiasis model
13. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia
14. Amphotericin B-resistant yeast infection in severely immunocompromised patients
15. Itraconazole resistance in Aspergillus fumigatus